I am a breastfeeding mother and i want to know if it is safe to use EINECS 202-363-2? Is EINECS 202-363-2 safe for nursing mother and child? Does EINECS 202-363-2 extracts into breast milk? Does EINECS 202-363-2 has any long term or short term side effects on infants? Can EINECS 202-363-2 influence milk supply or can EINECS 202-363-2 decrease milk supply in lactating mothers?
- DrLact safety Score for EINECS 202-363-2 is 3 out of 8 which is considered Low Risk as per our analyses.
- A safety Score of 3 indicates that usage of EINECS 202-363-2 may cause some minor side effects in breastfed baby.
- Our study of different scientific research indicates that EINECS 202-363-2 may cause moderate to no side effects in lactating mother.
- Most of scientific studies and research papers declaring usage of EINECS 202-363-2 low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- While using EINECS 202-363-2 We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Colorante azoico con efecto analgésico en la mucosa del tracto urinario. Uno de sus metabolitos es el paracetamol. Puede teñir las secreciones corporales de color anaranjado. Riesgo de metahemoglobinemia. A fecha de última actualización no encontramos datos publicados sobre su excreción en leche materna. Producto de farmacocinética poco estudiada y de eficacia limitada. Hasta conocer más datos sobre este fármaco, son preferibles alternativas conocidas más seguras, en especial en el periodo neonatal y en caso de prematuridad o déficit de glucosa-6PD.
The safety of EINECS 202-363-2 is not established in infants or during breastfeeding. Because it can cause methemoglobinemia, sulfhemoglobinemia, and hemolytic anemia, it should be avoided while breastfeeding, especially with an infant under 1 month of age or with glucose-6-phosphate dehydrogenase (G6PD) deficiency.
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.